RxDoctor Payments Data

Michelle Castiello

Foot Surgery · Eastchester, NYNPI 1386609063

Payments from drug & device makers

$379in general payments, 2019–2025

Across 7 payments — averaging $54.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$241
  • Integra Lifesciences Corporation$50
  • Treace Medical Concepts, Inc.$44
  • Smith+Nephew$28
  • Dynasplint Systems Inc.$16

What the payments were for

  • Food & beverage$379100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen(2 entities)2$241
Integra Lifesciences Corporation1$50
Treace Medical Concepts, Inc.2$44
Smith+Nephew1$28
Dynasplint Systems Inc.1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$379 in reported general payments places this provider in the 40th percentile of 294 foot surgery providers in New York.

See all foot surgery providers in New York

Medicare billing

Part B allowed, 2024
$230,458
Medicare patients
465
Services billed
2,596

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JubliaEfinaconazole15$17,768
Ciclopirox36$1,752
CiclopiroxCiclopirox Olamine49$1,162
Econazole Nitrate21$524
Mupirocin47$439

Paid to pharmacies, not to this prescriber.

Other foot surgery in Eastchester

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →